AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

TELIX PHARMACEUTICALS LTD

17.540

+0.6703.97%

Volume:1.34M

Turnover:23.14M

Market Cap:5.94B

PE:130.49

High:17.830

Open:16.870

Low:16.680

Close:16.870

52wk High:18.320

52wk Low:8.260

Shares:338.72M

Float Shares:275.41M

Volume Ratio:0.88

T/O Rate:0.49%

Dividend:- -

Dividend Rate:- -

EPS(TTM):0.134

EPS(LYR):-0.030

ROE:7.36%

ROA:2.71%

PB:8.65

PE(LYR):-589.90

Loading ...

Overview Company News Filings

3 ASX Growth Companies With Up To 34% Insider Ownership

Simply Wall St.

Fast Growing Australian Stocks With High Insider Ownership Worth A Closer Look

Simply Wall St.

Telix Pharmaceuticals Securing FDA Nod in Line With Expectations, Says Jefferies, Shares Down 3%

MT Newswires Live

Telix Pharmaceuticals (ASX:TLX) Clears FDA Trial Step, Does It Look Fairly Valued?

Simply Wall St.

Jefferies Sees Australia's Telix on Track for Timely U.S. Entry After Prostact FDA Clearance

Telix Pharmaceuticals Says FDA Alignment to Advance Prostact Global Phase 3 Trial

Australia's Telix Rises to over 9-month High as FDA Backs Prostact Study Advancement

Telix Pharmaceuticals Gets US FDA Nod to Advance Phase 3 Prostate Cancer Trial

MT Newswires Live

Telix Pharmaceuticals - Initiation of Part 2 in U.S. Subject to FDA Ind Amendment Review

THOMSON REUTERS

Telix Pharmaceuticals Ltd-fda Alignment to Advance Prostact Global Phase 3 Trial

THOMSON REUTERS

Telix Pharmaceuticals - FDA Confirms Part 1 Safety Data Sufficient for Part 2 Progression in U.S.

THOMSON REUTERS

3 Australian Growth Stocks With High Insider Ownership Worth Watching

Simply Wall St.

Is Telix (ASX:TLX) Using Vertical Integration To Quietly Redefine Its Radiopharmaceutical Moat?

Simply Wall St.

Telix Pharmaceuticals Stock Leads 3 Australian Growth Picks With High Insider Ownership

Simply Wall St.

Fast Growing Australian Stocks With High Insider Ownership Worth A Closer Look

Simply Wall St.

Telix Pharmaceuticals Stock And Two Australian Insider Led Growth Plays

Simply Wall St.

3 ASX Growth Stocks With Insider Backing That Deserve A Closer Look

Simply Wall St.

Stock Track | Telix Pharmaceuticals Soars 9.62% Intraday on Strong Pipeline and Commercial Imaging Revenue

ASX Biggest Gainers

MT Newswires Live

3 Australian Growth Stocks With High Insider Ownership And Funding Risk

Simply Wall St.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigerfiesta.com/stock/TLX.AU/news?page=5"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"TLX.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"TLX.AU\",,,,,undefined,":{"symbol":"TLX.AU","market":"AU","secType":"STK","nameCN":"TELIX PHARMACEUTICALS LTD","latestPrice":17.54,"timestamp":1789612027254,"preClose":16.87,"halted":0,"volume":1338510,"delay":0,"changeRate":0.03971547125074085,"nameEN":"TELIX PHARMACEUTICALS LTD","floatShares":275410996,"shares":338721355,"eps":0.134407056701612,"marketStatus":"Trading","change":0.67,"latestTime":"09-17 12:27:08 AEST","open":16.87,"high":17.83,"low":16.68,"amount":23136986,"amplitude":0.068168,"askPrice":17.55,"askSize":281,"bidPrice":17.54,"bidSize":469,"shortable":3,"etf":0,"ttmEps":0.134407056701612,"tradingStatus":2,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1789624800000},"marketStatusCode":2,"adr":0,"exchange":"ASX","adjPreClose":16.87,"openAndCloseTimeList":[[1789603200000,1789624800000]],"volumeRatio":0.877759,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"TLX.AU","preClose":16.87,"auctionPrice":16.87,"auctionVolume":263534,"auctionTime":1789603148263,"referenceTime":1789554603098,"auction":1,"marketStatus":"盘前竞价","timestamp":1789603148263}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"TLX.AU\",,,,,undefined,":{"symbol":"TLX.AU","floatShares":275410996,"roa":"2.71%","roe":"7.36%","lyrEps":-0.029734,"volumeRatio":0.877759,"shares":338721355,"dividePrice":0,"high":17.83,"amplitude":0.068168,"preClose":16.87,"low":16.68,"week52Low":8.26,"pbRate":"8.65","psRate":"4.73","week52High":18.32,"institutionHeld":0,"latestPrice":17.54,"committee":0.250667,"eps":0.13441917882347634,"divideRate":0,"volume":1338510,"delay":0,"ttmEps":0.13441917882347634,"open":16.87,"prevYearClose":11.2,"prevWeekClose":15.67,"prevMonthClose":15.36,"prevQuarterClose":16.58,"fiveDayClose":16.76,"twentyDayClose":17.38,"sixtyDayClose":15.68},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/TLX.AU\",params:#limit:5,,,undefined,":[{"date":"2026-08-20","symbol":"TLX.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1787184000000,"name":null,"time":"","dateTimestamp":1787148000000,"actualEps":null},{"date":"2026-02-19","symbol":"TLX.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1771455600000,"name":null,"time":"","dateTimestamp":1771419600000,"actualEps":null},{"date":"2026-01-19","symbol":"TLX.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1768777200000,"name":null,"time":"","dateTimestamp":1768741200000,"actualEps":null},{"date":"2025-08-21","symbol":"TLX.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1755734400000,"name":null,"time":"","dateTimestamp":1755698400000,"actualEps":null},{"date":"2025-02-19","symbol":"TLX.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1739919600000,"name":null,"time":"","dateTimestamp":1739883600000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"TLX.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"TLX.AU\",pageSize:20,pageCount:5,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2649619107","title":"3 ASX Growth Companies With Up To 34% Insider Ownership","url":"https://stock-news.laohu8.com/highlight/detail?id=2649619107","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649619107?lang=en_us&edition=fundamental","pubTime":"2026-07-06 03:08","pubTimestamp":1783278496,"startTime":"0","endTime":"0","summary":"As the Australian market opens the new financial year on a flat note, global influences such as geopolitical tensions and tech sector enthusiasm continue to shape investor sentiment. In this landscape, growth companies with high insider ownership can be particularly appealing, as they often signal strong internal confidence and alignment with shareholder interests.","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-tlx/telix-pharmaceuticals-shares/news/3-asx-growth-companies-with-up-to-34-insider-ownership","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-tlx/telix-pharmaceuticals-shares/news/3-asx-growth-companies-with-up-to-34-insider-ownership","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BEAR.AU","BK7067","ELS.AU","SKS.AU","AV1.AU","FRS.AU","EMR.AU","GEAR.AU","BK7016","AR1.AU","VAS.AU","TOR.AU","TLX","BK7017","IIGF.AU","STW.AU","BK7023","BBOZ.AU","AEM.AU","GYG.AU","XAO.AU","XJO.AU","OZR.AU","DACE.AU","BK7110","BK7104","IMLC.AU","MAF.AU","OZF.AU","PNI.AU","BK7508","BK7501","BK7084","VAP.AU","IISV.AU","EIGA.AU","BK4139","BK7095","BK7137","E200.AU","GIVE.AU","SPL.AU","IOZ.AU","BK7096","TLX.AU","XKO.AU","QRE.AU","SLF.AU","ZYAU.AU","QFN.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649659690","title":"Fast Growing Australian Stocks With High Insider Ownership Worth A Closer Look","url":"https://stock-news.laohu8.com/highlight/detail?id=2649659690","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649659690?lang=en_us&edition=fundamental","pubTime":"2026-07-05 08:29","pubTimestamp":1783211365,"startTime":"0","endTime":"0","summary":"With inflation trends easing in some regions, interest rate paths looking more measured, and growth signals mixed across major economies, many investors are looking for companies that can rely on their own earnings power rather than broad market momentum. Fast growing stocks with high insider ownership can fit that brief, because management teams have a meaningful stake in the outcome and analysts are optimistic about their prospects. This article profiles 3 stocks from the Fast Growing...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-tlx/telix-pharmaceuticals-shares/news/fast-growing-australian-stocks-with-high-insider-ownership-w-1","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-tlx/telix-pharmaceuticals-shares/news/fast-growing-australian-stocks-with-high-insider-ownership-w-1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["XAO.AU","XJO.AU","E200.AU","IOZ.AU","OZF.AU","BBOZ.AU","IIGF.AU","DACE.AU","VAP.AU","BK4139","IMLC.AU","BK7095","SLF.AU","GLF.AU","BK7145","TLX.AU","STW.AU","EIGA.AU","XKO.AU","GIVE.AU","BEAR.AU","OZR.AU","QRE.AU","TLX","BK7067","QFN.AU","ZYAU.AU","VAS.AU","LIN.AU","GEAR.AU","IISV.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648565514","title":"Telix Pharmaceuticals Securing FDA Nod in Line With Expectations, Says Jefferies, Shares Down 3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2648565514","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648565514?lang=en_us&edition=fundamental","pubTime":"2026-07-03 14:06","pubTimestamp":1783058769,"startTime":"0","endTime":"0","summary":"Telix Pharmaceuticals (ASX:TLX) reaching alignment with the US Food and Drug Administration (FDA) to advance a phase 3 trial of its TLX591-Tx therapeutic candidate is in line with expectations, accord","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4588","TLX.AU","BK7067","LABU","BK4139","TLX","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648410658","title":"Telix Pharmaceuticals (ASX:TLX) Clears FDA Trial Step, Does It Look Fairly Valued?","url":"https://stock-news.laohu8.com/highlight/detail?id=2648410658","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648410658?lang=en_us&edition=fundamental","pubTime":"2026-07-03 09:41","pubTimestamp":1783042878,"startTime":"0","endTime":"0","summary":"Telix Pharmaceuticals (ASX:TLX) is back in focus after a Type B meeting with the U.S. Food and Drug Administration confirmed that safety data from its ProstACT Global Phase 3 trial supports moving TLX591-Tx into Part 2.\nSee our latest analysis for Telix Pharmaceuticals.\nAlongside the FDA update, Telix Pharmaceuticals has drawn fresh attention after a strong 30-day share price return of 36.03% and year to date share price return of 51.23%. However, the 1-year total shareholder return declined...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-tlx/telix-pharmaceuticals-shares/news/telix-pharmaceuticals-asxtlx-clears-fda-trial-step-does-it-l","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-tlx/telix-pharmaceuticals-shares/news/telix-pharmaceuticals-asxtlx-clears-fda-trial-step-does-it-l","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["TLX.AU","BK4585","TLX","LABU","BK4139","BK7067","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648482680","title":"Jefferies Sees Australia's Telix on Track for Timely U.S. Entry After Prostact FDA Clearance","url":"https://stock-news.laohu8.com/highlight/detail?id=2648482680","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648482680?lang=en_us&edition=fundamental","pubTime":"2026-07-03 03:25","pubTimestamp":1783020348,"startTime":"0","endTime":"0","summary":"BUZZ-Jefferies sees Australia's Telix on track for timely U.S. entry after ProstACT FDA clearance** Jefferies says Telix’sTLX.AXProstACT trial for prostate cancer is progressing to a timely U.S. entry","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260702:nL6N4342IZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TLX.AU","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648578493","title":"Telix Pharmaceuticals Says FDA Alignment to Advance Prostact Global Phase 3 Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2648578493","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648578493?lang=en_us&edition=fundamental","pubTime":"2026-07-02 09:46","pubTimestamp":1782956811,"startTime":"0","endTime":"0","summary":"July 2 (Reuters) - Telix Pharmaceuticals Ltd::*FDA ALIGNMENT TO ADVANCE PROSTACT GLOBAL PHASE 3 TRIAL*FDA AND TELIX ALIGN TO ADVANCE PROSTACT GLOBAL PHASE 3 PART 2 IN U.S.*FDA CONFIRMS PART 1 SAFETY D","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260702:nRSD6NGldj:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TLX.AU","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648578138","title":"Australia's Telix Rises to over 9-month High as FDA Backs Prostact Study Advancement","url":"https://stock-news.laohu8.com/highlight/detail?id=2648578138","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648578138?lang=en_us&edition=fundamental","pubTime":"2026-07-02 09:35","pubTimestamp":1782956130,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's Telix rises to over 9-month high as FDA backs ProstACT study advancement** Shares of Telix PharmaceuticalsTLX.AXrise as much as 1.9% to A$17.35, hitting their highest level since Sept","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260702:nL4N434031:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TLX.AU","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648795527","title":"Telix Pharmaceuticals Gets US FDA Nod to Advance Phase 3 Prostate Cancer Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2648795527","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648795527?lang=en_us&edition=fundamental","pubTime":"2026-07-02 08:37","pubTimestamp":1782952632,"startTime":"0","endTime":"0","summary":"Telix Pharmaceuticals  reached alignment with the US Food and Drug Administration  to advance a phase 3 trial of its TLX591-Tx therapeutic candidate in metastatic castration-resistant prostate cancer, the company said Thursday.In a type B meeting, the US regulator confirmed that safety data from part one of the study is adequate to allow for progression of part two, the company said.The launch of part two in the US remains subject to the FDA's review of an investigational new drug amendment, per the statement.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","TLX.AU","BK7067","BK4588","BK4585","LABU","TLX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648527857","title":"Telix Pharmaceuticals - Initiation of Part 2 in U.S. Subject to FDA Ind Amendment Review","url":"https://stock-news.laohu8.com/highlight/detail?id=2648527857","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648527857?lang=en_us&edition=fundamental","pubTime":"2026-07-02 08:07","pubTimestamp":1782950852,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260702:nTUEQ4M95:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7067","TLX.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648352785","title":"Telix Pharmaceuticals Ltd-fda Alignment to Advance Prostact Global Phase 3 Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2648352785","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648352785?lang=en_us&edition=fundamental","pubTime":"2026-07-02 08:07","pubTimestamp":1782950852,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260702:nTUEQ4M95:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7067","TLX.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648278595","title":"Telix Pharmaceuticals - FDA Confirms Part 1 Safety Data Sufficient for Part 2 Progression in U.S.","url":"https://stock-news.laohu8.com/highlight/detail?id=2648278595","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648278595?lang=en_us&edition=fundamental","pubTime":"2026-07-02 08:07","pubTimestamp":1782950852,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260702:nTUEQ4M95:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TLX.AU","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648252272","title":"3 Australian Growth Stocks With High Insider Ownership Worth Watching","url":"https://stock-news.laohu8.com/highlight/detail?id=2648252272","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648252272?lang=en_us&edition=fundamental","pubTime":"2026-07-02 05:42","pubTimestamp":1782942141,"startTime":"0","endTime":"0","summary":"Global manufacturing, inflation and currency trends are moving in different directions across regions, so it helps to focus on companies where management has real skin in the game and growth remains a clear priority. That is exactly what the Fast Growing Stocks With High Insider Ownership screener aims to highlight, by filtering for businesses where insiders are heavily invested alongside you and analysts see strong prospects. In this article, you will see 3 stocks from that screener that...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-tlx/telix-pharmaceuticals-shares/news/3-australian-growth-stocks-with-high-insider-ownership-worth","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-tlx/telix-pharmaceuticals-shares/news/3-australian-growth-stocks-with-high-insider-ownership-worth","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["SLF.AU","XKO.AU","VAP.AU","IIGF.AU","ZYAU.AU","GLF.AU","OZR.AU","IOZ.AU","GEAR.AU","STW.AU","XAO.AU","BK7145","VAS.AU","LIN.AU","XJO.AU","BEAR.AU","E200.AU","QFN.AU","IMLC.AU","BBOZ.AU","BK7067","TLX","OZF.AU","GIVE.AU","DACE.AU","EIGA.AU","IISV.AU","BK7095","BK4139","QRE.AU","TLX.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648481365","title":"Is Telix (ASX:TLX) Using Vertical Integration To Quietly Redefine Its Radiopharmaceutical Moat?","url":"https://stock-news.laohu8.com/highlight/detail?id=2648481365","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648481365?lang=en_us&edition=fundamental","pubTime":"2026-07-01 19:33","pubTimestamp":1782905584,"startTime":"0","endTime":"0","summary":"In late June 2026, Telix Pharmaceuticals held a special call highlighting continued commercial traction for its radiopharmaceutical portfolio, growing international reach, and ongoing clinical and partnership progress in precision oncology.\nAn interesting takeaway is the use of vertical integration and deal-making across manufacturing and distribution to strengthen Telix’s position as a global radiopharmaceutical competitor.\nWe’ll now explore how this emphasis on vertical integration and...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-tlx/telix-pharmaceuticals-shares/news/is-telix-asxtlx-using-vertical-integration-to-quietly-redefi","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-tlx/telix-pharmaceuticals-shares/news/is-telix-asxtlx-using-vertical-integration-to-quietly-redefi","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["TLX.AU","BK4139","BK7067","TLX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647336035","title":"Telix Pharmaceuticals Stock Leads 3 Australian Growth Picks With High Insider Ownership","url":"https://stock-news.laohu8.com/highlight/detail?id=2647336035","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647336035?lang=en_us&edition=fundamental","pubTime":"2026-06-30 12:30","pubTimestamp":1782793810,"startTime":"0","endTime":"0","summary":"With central banks rethinking interest rate paths, inflation signals mixed across regions, and consumer and trade data sending uneven messages, many investors are looking for growth stories that are grounded in management commitment rather than short term momentum. Fast Growing Stocks With High Insider Ownership focuses on companies where insiders have meaningful skin in the game and where analysts and management share an optimistic outlook. That combination can appeal if you want growth...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-tlx/telix-pharmaceuticals-shares/news/telix-pharmaceuticals-stock-leads-3-australian-growth-picks","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-tlx/telix-pharmaceuticals-shares/news/telix-pharmaceuticals-stock-leads-3-australian-growth-picks","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BEAR.AU","IMLC.AU","XKO.AU","BK7095","XJO.AU","IISV.AU","EIGA.AU","GEAR.AU","E200.AU","TLX","GIVE.AU","OZR.AU","VAS.AU","ZYAU.AU","IOZ.AU","QFN.AU","TLX.AU","XAO.AU","STW.AU","BK7067","GLF.AU","QRE.AU","DACE.AU","BK4139","IIGF.AU","VAP.AU","OZF.AU","LIN.AU","SLF.AU","BK7145","BBOZ.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647340699","title":"Fast Growing Australian Stocks With High Insider Ownership Worth A Closer Look","url":"https://stock-news.laohu8.com/highlight/detail?id=2647340699","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647340699?lang=en_us&edition=fundamental","pubTime":"2026-06-29 09:14","pubTimestamp":1782695674,"startTime":"0","endTime":"0","summary":"With AI investment picking up in China, bond yields easing in several markets and consumers still spending even as inflation pressures linger, many investors are looking for companies that can grow through different parts of the cycle. Fast growing stocks with high insider ownership can be especially interesting, because management has meaningful skin in the game alongside outside shareholders. The screener used here focuses on companies where analysts and management share an optimistic...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-tlx/telix-pharmaceuticals-shares/news/fast-growing-australian-stocks-with-high-insider-ownership-w","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-tlx/telix-pharmaceuticals-shares/news/fast-growing-australian-stocks-with-high-insider-ownership-w","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["XJO.AU","BK7095","IIGF.AU","IOZ.AU","XKO.AU","BK7145","EIGA.AU","GIVE.AU","XAO.AU","QFN.AU","DACE.AU","GLF.AU","QRE.AU","VAS.AU","GEAR.AU","LIN.AU","STW.AU","BBOZ.AU","E200.AU","VAP.AU","IISV.AU","TLX.AU","TLX","OZR.AU","IMLC.AU","BK4139","OZF.AU","BEAR.AU","BK7067","SLF.AU","ZYAU.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646100390","title":"Telix Pharmaceuticals Stock And Two Australian Insider Led Growth Plays","url":"https://stock-news.laohu8.com/highlight/detail?id=2646100390","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646100390?lang=en_us&edition=fundamental","pubTime":"2026-06-27 22:17","pubTimestamp":1782569834,"startTime":"0","endTime":"0","summary":"With inflation indicators mixed, central banks cautious on rates, and sector performance split between stronger services and softer manufacturing, many investors are looking for individual stocks that combine clear growth stories with management teams that have real skin in the game. The Fast Growing Stocks With High Insider Ownership screener focuses on companies where growth expectations from analysts and management line up, and insiders hold meaningful stakes. That combination can help you...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-tlx/telix-pharmaceuticals-shares/news/telix-pharmaceuticals-stock-and-two-australian-insider-led-g","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-tlx/telix-pharmaceuticals-shares/news/telix-pharmaceuticals-stock-and-two-australian-insider-led-g","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["IISV.AU","IOZ.AU","GEAR.AU","XKO.AU","XJO.AU","XAO.AU","ZYAU.AU","BK4139","EIGA.AU","IIGF.AU","OZF.AU","LIN.AU","STW.AU","OZR.AU","VAP.AU","QRE.AU","BK7145","DACE.AU","VAS.AU","BK7095","GLF.AU","TLX","QFN.AU","E200.AU","BK7067","BBOZ.AU","BEAR.AU","IMLC.AU","TLX.AU","GIVE.AU","SLF.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646924383","title":"3 ASX Growth Stocks With Insider Backing That Deserve A Closer Look","url":"https://stock-news.laohu8.com/highlight/detail?id=2646924383","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646924383?lang=en_us&edition=fundamental","pubTime":"2026-06-26 02:17","pubTimestamp":1782411432,"startTime":"0","endTime":"0","summary":"With inflation, interest rates and global growth expectations all pulling markets in different directions, many investors are looking for companies where insiders have meaningful skin in the game and analysts see room for further expansion. That is exactly what the Fast Growing Stocks With High Insider Ownership screener focuses on. It highlights businesses where management conviction and growth potential align. This combination can help you focus on stocks that are not only growing quickly,...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/2054000-choice2-main-header/1585187245570","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/2054000-choice2-main-header/1585187245570"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/materials/asx-ipx/iperionx-shares/news/3-asx-growth-stocks-with-insider-backing-that-deserve-a-clos","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/materials/asx-ipx/iperionx-shares/news/3-asx-growth-stocks-with-insider-backing-that-deserve-a-clos","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4139","REMX","BK7116","IPX.AU","BK7095","TLX","LIN.AU","BK7067","TLX.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1120285849","title":"Stock Track | Telix Pharmaceuticals Soars 9.62% Intraday on Strong Pipeline and Commercial Imaging Revenue","url":"https://stock-news.laohu8.com/highlight/detail?id=1120285849","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1120285849?lang=en_us&edition=fundamental","pubTime":"2026-06-24 10:44","pubTimestamp":1782269074,"startTime":"0","endTime":"0","summary":"Telix Pharmaceuticals Ltd (ASX:TLX) saw its stock price surge 9.62% during intraday trading on Wednesday.The company, which develops radiopharmaceutical imaging agents and therapies for cancers, is...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["TLX.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645883866","title":"ASX Biggest Gainers","url":"https://stock-news.laohu8.com/highlight/detail?id=2645883866","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645883866?lang=en_us&edition=fundamental","pubTime":"2026-06-24 10:40","pubTimestamp":1782268808,"startTime":"0","endTime":"0","summary":"Here are the ASX-listed companies with the biggest gains on Wednesday.Wisetech Global : +13%, AU$32.51BCI Minerals : +11%, AU$0.42Anteris Technologies : +10%, AU$14.99Xero : +8%, AU$70.31Telix Pharmaceuticals : +7%, AU$15.54Neuren Pharmaceuticals : +5%, AU$12.99Tasmea : +5%, AU$9.45Lindian Resources : +5%, AU$0.92Regis Healthcare : +4%, AU$6.53Iluka Resources : +4%, AU$7.54","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["TEA.AU","BK7007","AVR.AU","ILU.AU","BK7095","BK7129","BK7067","BCI.AU","XRO.AU","WTC.AU","BK7113","BK7503","TLX.AU","BK7508","LIN.AU","BK7096","BK7016","BK7055","NEU.AU","REG.AU","BK7126"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645857911","title":"3 Australian Growth Stocks With High Insider Ownership And Funding Risk","url":"https://stock-news.laohu8.com/highlight/detail?id=2645857911","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645857911?lang=en_us&edition=fundamental","pubTime":"2026-06-24 07:00","pubTimestamp":1782255617,"startTime":"0","endTime":"0","summary":"With growth readings around the world sending mixed signals and services sectors under pressure in many major economies, investors are paying closer attention to stocks where management and insiders are firmly aligned with shareholders. The Fast Growing Stocks With High Insider Ownership screener filters for companies that combine strong growth potential with management teams that analysts and insiders view positively. That combination can help you focus on businesses where leaders have...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/2054000-choice2-main-header/1585187245570","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/2054000-choice2-main-header/1585187245570"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/materials/asx-ipx/iperionx-shares/news/3-australian-growth-stocks-with-high-insider-ownership-and-f","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/materials/asx-ipx/iperionx-shares/news/3-australian-growth-stocks-with-high-insider-ownership-and-f","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["QFN.AU","QRE.AU","GEAR.AU","EIGA.AU","VAS.AU","XAO.AU","GIVE.AU","DACE.AU","VAP.AU","IIGF.AU","BBOZ.AU","BK4139","E200.AU","IISV.AU","XJO.AU","ZYAU.AU","BK7116","IPX.AU","TLX","XKO.AU","OZR.AU","LIN.AU","BK7067","IMLC.AU","IOZ.AU","STW.AU","BK7095","SLF.AU","BEAR.AU","OZF.AU","TLX.AU"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":5,"totalSize":198,"code":"91000000","status":"200"}]}}